Acquired and congenital cholesteatoma: Determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process

ORL

Volumn 62, Issue 5, 2000, Pages 257-265

  Akimoto, Rika ^a   Pawankar, Ruby ^a   Yagi, Toshiaki ^a   Baba, Shunichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acquired cholesteatoma; Bone resorption; Congenital cholesteatoma; Intercellular adhesion molecule 1; Lymphocyte functional antigen 1; Tumor necrosis factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHOLESTEATOMA; CLINICAL ARTICLE; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033799097     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027756     Document Type: Article

References (26)

1. 125I labelled human tumor necrosis factor (LULII) to specific cell surface receptors. J Exp Med 1985;162:1099-1104.
2. Erater-Schoder M, Risan W, Hallman R, Gautschi P, Bohlen P: Tumor necrosis factor type x, a potent inhibitor of endothelial growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987;84:5277-5281.
3. Kurihama A, Toshima MR, Yuasa R, Takasaka T: Bone resorption mechanisms in chronic otitis media with cholesteatoma: Specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha. Ann Otol Rhinol Laryngol 1991; 100:989-998.
4. Yan S, Huang C: The role of tumor necrosis factor in bone resorption of cholesteatoma. Am J Otolaryngol 1991;100:85-88.
5. Amar MS, Wishahi HF, Zakhary MM: Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol 1996;110:534-539.
6. Kinoshita T: The roles of interleukin-1α, tumor necrosis factor-α and parathyroid hormone in bone resorption of cholesteatoma otitis. J Otolaryngol 1994;95:1472.
7. Ahn J, Huang CC, Abramson M: Localization of interleukin-1 in human cholesteatoma. Am J Otolaryngol 1990;11:71-77.
8. Yagita H, Okumura K: The role of adhesion molecules in triggering effector mechanisms; in Nariuchi H, Okada H, Okumura K, Takatsuki K, Yodoi J: Molecular Basis of Immune Responses. Tokyo, Academic Press, 1993, pp 59-70.
9. Sreeter PR, Berg EL, Bich Tien NR, Bargatse RF, Butcher EC: A tissue specific endothelial cell molecule involved in lymphocyte homing. Nature 1988;331:41-46.
10. Dustin ML, Stauton DE, Springer TA: Supergene families in the immune system. Immunol Today 1988;9:213-215.
11. Rothlin R, Dustin ML, Marlin SD, Springer TA: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986;137:1270-1274.
12. Wegner CD, Rothlein R, Clarke CC, Haynes N, Torcellini CA, La Plante AM, Averill DR, Letts LG, Gundel RH: Inhaled anti-ICAM-1 reduced antigen-induced airway hyperresponsiveness in monkeys. Am Rev Respir Dis 1991; 143:A418.
13. Dustin ML, Rothlein BR, Brian AK, Dinarello CA, Springer TA: Induction by IL-1 and interferon-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-254.
14. Derlacki EL, Clemis JD: Congenital cholesteatoma of the middle ear and mastoid. Ann Otol Rhinol Laryngol 1965;74:706-727.
15. Yokoshima K: An analysis of primary cholesteatomas. Otolaryngol Head Neck Surg 1994; 66:250-254.
16. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
17. Pawankar R, Okuda M, Hasegawa S, Suzuki K, Yssel H, Okubo K, Okumura K, Ra C: Interleukin-13 gene expression in the nasal mucosa of perennial allergic rhinities. Am J Respir Crit Care Med 1995;152:2059-2067.
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
19. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson BD: An endotoxin-induced serum factor that causes necrosis of tumor. Proc Natl Acad Sci 1975;72:3666-3670.
20. Clark IA, Codwen WB, Butcher GA, Hunt NH: Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol 1987;129: 192-199.
21. Shiwa M, Kojima H, Kamide Y, Moriyama H: Involvement of interleukin-1 in middle ear cholesteatoma. Am J Otol 1995;16:319-324.
22. Felix R, Fleisch H, Elford PR: Bone-resorbing cytokines enhance release of macrophage colony stimulating activity by the osteoblastic cell MC3T3-E1. Calcif Tissue Int 1989;44:356-360.
23. Robinson DR, Tshjian AH, Levine L: Prostaglandin stimulated bone resorption by rheumatoid synovia: A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975;56:1181-1188.
24. Toshima M: Cholesteatoma with otitis media: Bone resorption mechanisms and cytokines. Otol Jpn 1997;7:158-163.
25. Shinoda H, Huang CC: Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma. Eur Arch Otolaryngol 1995;252: 385-390.
26. Pawankar R, Ra C: Heterogeneity of mast cells and T cells in the nasal mucosa. J Allergy Clin Immunol 1996;98:248-262.